EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects.
Paskeh MDA, Mehrabi A, Gholami MH, Zabolian A, Ranjbar E, Saleki H, Ranjbar A, Hashemi M, Ertas YN, Hushmandi K, Mirzaei S, Ashrafizadeh M, Zarrabi A, Samarghandian S.
Paskeh MDA, et al. Among authors: ashrafizadeh m.
Biomed Pharmacother. 2022 Feb;146:112532. doi: 10.1016/j.biopha.2021.112532. Epub 2021 Dec 11.
Biomed Pharmacother. 2022.
PMID: 34906772
Free article.
Review.